Creative Medical Technology Holdings, Inc. Proceeds from Issuance of Warrants
Creative Medical Technology Holdings, Inc. (CELZ) reported Proceeds from Issuance of Warrants of $4.20 million for the 1-month period ending 2025-10-29, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-05-08
- Creative Medical Technology Holdings, Inc. proceeds from issuance of warrants for the quarter ending 2025-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from issuance of warrants for the quarter ending 2025-03-31 was $3.36M.
- Creative Medical Technology Holdings, Inc. proceeds from issuance of warrants for the quarter ending 2024-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from issuance of warrants for the quarter ending 2024-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. proceeds from issuance of warrants for fiscal 2021 was $2.10M.
| Period end | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2025-10-29 | $4.20M 10-Q · filed 2026-05-08 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.36M 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | $3.36M 10-Q · filed 2025-05-09 | |||||
| 2025-03-06 | $3.70M 10-Q · filed 2026-05-08 | |||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.10M derived: sum of 2 quarters · filed 2023-03-31 | $2.10M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $2.10M 10-Q · filed 2022-11-10 | $2.10M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |